Companies  » Health Care
 

Big opportunities opening for Cipla

Respiratory product paves way for launch in larger markets and greater earnings visibility

Cipla launches copy of GSK's top asthma drug in Germany, Sweden

01 Sep 2014

Cipla's drug will be marketed under the name Serrofloin in Germany and Salmeterol/Fluticasone Cipla in Sweden

Apollo to invest Rs 400 cr to open 3 hospitals by FY15-end

01 Sep 2014

Healthcare major Apollo Hospitals Enterprise plans to add 3 more reach hospitals with a total bed capacity of 500 beds in the country at an ...

Wockhardt gains 5% post USFDA fast-tracks nod for anti-infection drugs

01 Sep 2014

The company has received QIDP status from the USFDA for two of its drugs, WCK 771 and WCK 2349.

Wockhardt drug discovery gets fast track approval from USFDA

01 Sep 2014

Wockhardt today said its new drug discovery programme in anti-infective research has received a major boost after two of its drugs, WCK 771 and ...

US FDA fast-tracks approval for Wockhardt drugs

01 Sep 2014

Drugs were granted 5-years extension to the drug patents in the US

Ranbaxy now a mid-cap stock

01 Sep 2014

Until March this year, the company was part of the benchmark Nifty index

Online pharmacy Medybiz to tie up with insurance cos to boost growth

31 Aug 2014

Sees huge potential in day-care market, seeks tie up with those firms that also cover such expenses

USFDA grants QIDP status to two Wockhardt drugs

31 Aug 2014

Drug maker Wockhardt today said that two of its anti-infective drugs have received Qualified Infectious Disease Product (QIDP) status from the ...

Weekly: Markets gain on growth signs

30 Aug 2014

Sensex gains seventh month in a row rises 0.8% for week ended August 28, Nifty up 0.5%

Natco gets USFDA acceptance for generic Copaxone

30 Aug 2014

BS ReporterHyderabad, 30 Aug:Hyderabad-based Natco Pharma Limited stated that its marketing partner in the US, Mylan Inc, has filed an ...

Sun-Ranbaxy deal stirs monopoly concerns: CCI

30 Aug 2014

Competition watchdog says 'high market concentration' in some segments a worry

Sun-Ranbaxy deal: CCI raises concerns about molecules market

29 Aug 2014

The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, today said the major issue is whether ...

In race for bigger margins, drug makers willing to lose the India 'advantage'

29 Aug 2014

Indian drugmakers are fleeing a regulatory morass at home and moving some research and development to Europe and the United States as they try ...

CCI expands probe into Sun-Ranbaxy deal; seeks public scrutiny

28 Aug 2014

Widening its scrutiny of the multi-billion dollar Sun Pharma-Ranbaxy deal, fair trade watchdog CCI has asked the two pharma majors to make ...

Piramal Enterprises to stop early-stage research

28 Aug 2014

To focus on molecules at advanced stage of development; move to impact 200 scientists

Apollo Hospitals launches eAccess

27 Aug 2014

Service launched in collaboration with Philips with a capacity to monitor 500 beds from a command center

CCI gives green signal to Sanofi-Apollo deal

27 Aug 2014

The Competition Commission has cleared pharmaceutical firm Sanofi-Synthelabo's proposed stake buy in an arm of Apollo group, saying the deal ...

Venus Remedies surges 6% on pact with Teva for anti-cancer drug

27 Aug 2014

The pharmaceutical company has entered into an agreement with Israel-based generic drug maker Teva for selling an anti-cancer drug in Canada.

Quick Links

Advertisement


Back to Top